NAVELBINE 50 mg/5 ml, solution for injection in a vial 10 bottles of 5 ml
Active ingredients: Vinorelbine L-tartrate, Vinorelbine
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection10 bottles of 5 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NAVELBINE 50 mg/5 ml, solution injectable en flacon
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 10 flacon(s) en verre de 5 ml
- Marketing authorisation holder
- PIERRE FABRE MEDICAMENT
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Jan 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61168991CIP73318458CIP133400933184582Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| VINORELBINEsolution | 50 mg · 5 ml de solution injectable | FT |
| DITARTRATE DE VINORELBINEsolution | 69,25 mg · 5 ml de solution injectable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.